Pharmaceutical

AbbVie signs agreement to acquire Aliada for $1.4bn

AbbVie has entered a definitive agreement to acquire all outstanding equity of Aliada Therapeutics in a deal valued at $1.4bn in cash.

Oct 30, 2024 - 04:00
AbbVie signs agreement to acquire Aliada for $1.4bn
AbbVie has entered a definitive agreement to acquire all outstanding equity of Aliada Therapeutics in a deal valued at $1.4bn in cash.
Read the original article

Tags:

Previous Article

South Korean pricing reform suggests more flexible drug reimbursement negotiations

Next Article

Transforming pharmaceutical R&D: the impact of digital technologies on drug disc...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

IGM jettisons workforce and blood cancer programme to refocus pipeline

IGM jettisons workforce and blood cancer programme to r...

Dec 6, 2023

Coya stretches lead drug’s development to Parkinson’s and dementia

Coya stretches lead drug’s development to Parkinson’s a...

Jan 17, 2024

Alvotech and Dr Reddy’s partner to commercialise AVT03

Alvotech and Dr Reddy’s partner to commercialise AVT03

May 23, 2024